Ambev (ABEV) Stock Forecast & Price Target

Q: What analysts cover Ambev?

Ambev has been rated by research analysts at Scotiabank , UBS Group , and Weiss Ratings in the past 90 days.

$3.03 -0.01 (-0.33%)

As of 09/4/2026 03:58 PM Eastern

Compare

Ambev - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Reduce

Based on 6 Analyst Ratings

Sell
1

Hold
5

Buy
0

Based on 6 Wall Street analysts who have issued ratings for Ambev in the last 12 months, the stock has a consensus rating of "Reduce." Out of the 6 analysts, 1 has given a sell rating, and 5 have given a hold rating for ABEV.

Consensus Price Target

$3.08
1.54% Upside

According to the 6 analysts' twelve-month price targets for Ambev, the average price target is $3.08. The highest price target for ABEV is $3.50, while the lowest price target for ABEV is $2.85. The average price target represents a forecasted upside of 1.54% from the current price of $3.03.

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Get the Latest News and Ratings for ABEV and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Ambev and its competitors.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ABEV Analyst Ratings Over Time

Type	Current Forecast 9/5/25 to 9/5/26	1 Month Ago 8/6/25 to 8/6/26	3 Months Ago 6/7/25 to 6/7/26	1 Year Ago 9/5/24 to 9/5/25
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	0 Buy rating(s)	0 Buy rating(s)	0 Buy rating(s)	0 Buy rating(s)
Hold	5 Hold rating(s)	5 Hold rating(s)	5 Hold rating(s)	5 Hold rating(s)
Sell	1 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)
Consensus Price Target	$3.08	$3.09	$3.09	$2.35
Forecasted Upside	1.54% Upside	2.60% Upside	-1.01% Downside	5.62% Upside
Consensus Rating	Reduce	Reduce	Reduce	Reduce

ABEV Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

ABEV Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Ambev Stock vs. The Competition

Type	Ambev	Consumer Staples Companies	Broader Market
Consensus Rating Score	1.83	2.22	2.53
Consensus Rating	Reduce	Hold	Moderate Buy
Predicted Upside	1.54% Upside	147.74% Upside	14.03% Upside
News Sentiment Rating	Positive News See Recent ABEV News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export

Date	Brokerage	Analyst	Action	Rating	Price Target	Report Date Upside/Downside
8/11/2026	UBS Group 4 of 5 stars	Rodrigo Alcantara Not Rated	Set Target		$2.85	-1.21%
8/3/2026	Weiss Ratings 5 of 5 stars		Reiterated Rating	Hold (C+)
7/15/2026	Scotiabank 4 of 5 stars	Felipe Ucros Not Rated	Downgrade	Sector Outperform ➝ Sector Perform
5/6/2026	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Benjamin Theurer Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Equal Weight	$3.00 ➝ $3.50	+3.70%
11/26/2025	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Nadine Sarwat Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Outperform ➝ Market Perform	$2.88	+14.97%
9/30/2025	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Upgrade	Strong Sell ➝ Hold
8/1/2025	HSBC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Carlos Laboy Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Buy ➝ Hold
4/7/2025	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Downgrade	Equal Weight ➝ Underweight
1/22/2025	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Renata Cabral Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Buy ➝ Neutral
1/17/2025	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Downgrade	Buy ➝ Neutral
Get the Latest News and Ratings for ABEV and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Ambev and its competitors with MarketBeat's FREE daily newsletter.

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 12:01 AM ET.

Should I Buy Ambev Stock? ABEV Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Thursday, September 3, 2026. Please send any questions or comments about these Ambev pros and cons to contact@marketbeat.com.

Ambev
Bull Case

Here are some ways that investors could benefit from investing in Ambev S.A.:

Ambev S.A. recently concluded its share buyback program and approved the cancellation of 279 million common shares held in treasury, a move that reduces the total number of shares outstanding and can increase the earnings per share for remaining shareholders.
The company delivered strong second-quarter results with 6.1% net revenue growth and 24% normalized earnings per share growth, demonstrating robust market share gains in Brazil and the ability to expand margins despite a challenging macro environment.
Ambev S.A. is currently trading at $3.05, which is below the average analyst price target of $3.08 and significantly lower than the $3.50 target set by Barclays, suggesting the stock may be undervalued relative to its intrinsic value and recent performance.
With a low beta of 0.64, the stock exhibits less volatility than the broader market, making it a potentially stable investment option for investors seeking to reduce portfolio risk while maintaining exposure to the consumer staples sector.
Ambev S.A. maintains a consistent dividend policy with a payout ratio of 15.00%, providing a steady income stream for investors while retaining the majority of earnings for reinvestment and growth initiatives.

Ambev
Bear Case

Investors should be bearish about investing in Ambev S.A. for these reasons:

The consensus rating from investment analysts is "Reduce," with five analysts assigning a Hold rating and one assigning a Sell rating, indicating a general lack of strong bullish sentiment among professional investors.
Recent insider activity shows significant selling, including a director selling 468,040 shares and other insiders reducing their stakes, which may signal a lack of confidence in the stock's near-term upside potential.
Ambev S.A. reported second-quarter revenue of $3.89 billion, which missed analyst estimates of $4.05 billion, suggesting potential challenges in meeting top-line growth expectations despite strong earnings performance.
The company faces uncertainty from Brazil's upcoming general election, which could impact the macroeconomic environment and consumer spending patterns, adding a layer of geopolitical risk to the investment.
Short interest data shows that approximately 0.83% of the float is currently shorted, with days to cover at 3.92, indicating that some market participants are betting against the stock's price appreciation.

ABEV Forecast - Frequently Asked Questions

According to the research reports of 6 Wall Street equities research analysts, the average twelve-month stock price forecast for Ambev is $3.08, with a high forecast of $3.50 and a low forecast of $2.85.

6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Ambev in the last year. There is currently 1 sell rating and 5 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "reduce" ABEV shares.

According to analysts, Ambev's stock has a predicted upside of 1.54% based on their 12-month stock forecasts.

Over the previous 90 days, Ambev's stock had 1 downgrade by analysts.

Ambev has been rated by research analysts at Scotiabank, UBS Group, and Weiss Ratings in the past 90 days.

Analysts like Ambev less than other "consumer staples" companies. The consensus rating for Ambev is Reduce while the average consensus rating for "consumer staples" companies is Hold. Learn more on how ABEV compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Ambev Recommendations

MarketBeat monitors more than a dozen sources for Ambev analyst ratings, with the most recent rating issued on 8/11/2026.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Ambev (ABEV) Stock Forecast & Price Target